For patients with Crohn's disease, these effects could potentially: Mimic or mask disease flare symptoms, making it difficult to distinguish medication side effects from disease activity Exacerbate existing gastrointestinal symptoms, reducing quality of life Complicate nutritional management and absorption of other medications Increase the risk of dehydration, particularly if diarrhoea is already present Serious risks associated with GLP-1 receptor agonists include: Acute pancreatitis : Patients should be advised to seek immediate medical attention if they experience severe, persistent abdominal pain radiating to the back, as this may indicate pancreatitis
Safety remains our primary priority, so we establish clear safety netting regarding when to seek urgent medical help
Once fat cells are surgically removed, they do not grow back
Your team will decide on the best injection site for you
Article 7 mins Why Organizations Need a Robust Directors and Officers Risk Program A variety of growing risks, including shareholder derivative actions, an evolving regulatory environment and bankruptcy filings, are why public and private organizations must protect their corporate directors and officers